{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Cox model execution - 1st article\n",
    "In this notebook, we test the Cox model for the data from the following article : https://doi.org/10.1158/1078-0432.CCR-20-1163. The metrics we will use here is the Overall Survival (OS)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "from survivalAnalysis.CoxModel import CoxModel"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "coxmodel = CoxModel()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Reading and preprocessing\n",
    "We read the ```data/Supplemental-table1.xlsx``` file, and we drop the non-naive patients from the dataframe."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Anonymous ID</th>\n",
       "      <th>EGA ID</th>\n",
       "      <th>Tumour type</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Line of therapy</th>\n",
       "      <th>Immunotherapy regimen</th>\n",
       "      <th>Cohort</th>\n",
       "      <th>Reason for discontinuation</th>\n",
       "      <th>Best response</th>\n",
       "      <th>Age at advanced disease diagnosis</th>\n",
       "      <th>...</th>\n",
       "      <th>Alive_0</th>\n",
       "      <th>Time to progression (days)</th>\n",
       "      <th>Progression_1</th>\n",
       "      <th>Clinical benefit</th>\n",
       "      <th>CD8+ T cell score</th>\n",
       "      <th>Exome mut per mb</th>\n",
       "      <th>Genome mut per mb</th>\n",
       "      <th>CD274 expression</th>\n",
       "      <th>M1M2 expression</th>\n",
       "      <th>Lymph related</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>14891</td>\n",
       "      <td>EGAD00001001961</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>8</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Mixed</td>\n",
       "      <td>45</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>179</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.351869</td>\n",
       "      <td>11.095310</td>\n",
       "      <td>23.0729</td>\n",
       "      <td>4.1689</td>\n",
       "      <td>55.51575</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>18624</td>\n",
       "      <td>EGAD00001002047</td>\n",
       "      <td>AECA</td>\n",
       "      <td>F</td>\n",
       "      <td>10</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>47</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>148</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.071464</td>\n",
       "      <td>3.876336</td>\n",
       "      <td>5.4552</td>\n",
       "      <td>0.7910</td>\n",
       "      <td>9.32352</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>21392</td>\n",
       "      <td>EGAD00001002544</td>\n",
       "      <td>OV</td>\n",
       "      <td>F</td>\n",
       "      <td>6</td>\n",
       "      <td>Monalizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>57</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>79</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.040394</td>\n",
       "      <td>2.415688</td>\n",
       "      <td>4.1274</td>\n",
       "      <td>4.0377</td>\n",
       "      <td>50.12008</td>\n",
       "      <td>Lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>21516</td>\n",
       "      <td>EGAD00001002546</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Ipilimumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Not evaluable</td>\n",
       "      <td>29</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>11</td>\n",
       "      <td>0</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.052774</td>\n",
       "      <td>6.235845</td>\n",
       "      <td>11.4871</td>\n",
       "      <td>0.6006</td>\n",
       "      <td>1.58550</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>22186</td>\n",
       "      <td>EGAD00001001966</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>4</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>52</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>80</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.009323</td>\n",
       "      <td>4.606660</td>\n",
       "      <td>7.1503</td>\n",
       "      <td>1.8234</td>\n",
       "      <td>38.42695</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>39280</td>\n",
       "      <td>EGAD00001004933</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Toxicity</td>\n",
       "      <td>Physician Assessed SD</td>\n",
       "      <td>60</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>401</td>\n",
       "      <td>0</td>\n",
       "      <td>DCB</td>\n",
       "      <td>0.695396</td>\n",
       "      <td>84.998501</td>\n",
       "      <td>96.4079</td>\n",
       "      <td>8.4768</td>\n",
       "      <td>86.62561</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>37899</td>\n",
       "      <td>EGAD00001005838</td>\n",
       "      <td>CHOL</td>\n",
       "      <td>F</td>\n",
       "      <td>2</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Physician assessed PR</td>\n",
       "      <td>38</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>96</td>\n",
       "      <td>0</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.818233</td>\n",
       "      <td>2.247151</td>\n",
       "      <td>2.7416</td>\n",
       "      <td>11.2704</td>\n",
       "      <td>47.97376</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>37775</td>\n",
       "      <td>EGAD00001004934</td>\n",
       "      <td>HNSC</td>\n",
       "      <td>M</td>\n",
       "      <td>1</td>\n",
       "      <td>Avelumab/OX40 agonist PF-04518600</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>69</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>69</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.018982</td>\n",
       "      <td>3.848247</td>\n",
       "      <td>5.8036</td>\n",
       "      <td>8.7136</td>\n",
       "      <td>5.13403</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>38313</td>\n",
       "      <td>EGAD00001005844</td>\n",
       "      <td>ACC</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Avelumab/Debio1143 (SMAC mimetic)</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Toxicity</td>\n",
       "      <td>Partial response</td>\n",
       "      <td>34</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>51</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>5.617878</td>\n",
       "      <td>7.7940</td>\n",
       "      <td>0.0688</td>\n",
       "      <td>0.51364</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>38207</td>\n",
       "      <td>EGAD00001005850</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>1</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>50</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>104</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.110416</td>\n",
       "      <td>33.763449</td>\n",
       "      <td>53.2769</td>\n",
       "      <td>23.8818</td>\n",
       "      <td>11.22022</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>82 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Anonymous ID           EGA ID Tumour type Sex Line of therapy   \n",
       "0          14891  EGAD00001001961        LUNG   F               8  \\\n",
       "1          18624  EGAD00001002047        AECA   F              10   \n",
       "2          21392  EGAD00001002544          OV   F               6   \n",
       "3          21516  EGAD00001002546        SKCM   F               3   \n",
       "4          22186  EGAD00001001966        LUNG   F               4   \n",
       "..           ...              ...         ...  ..             ...   \n",
       "92         39280  EGAD00001004933        LUNG   M               2   \n",
       "94         37899  EGAD00001005838        CHOL   F               2   \n",
       "95         37775  EGAD00001004934        HNSC   M               1   \n",
       "96         38313  EGAD00001005844         ACC   F               3   \n",
       "97         38207  EGAD00001005850        LUNG   F               1   \n",
       "\n",
       "                Immunotherapy regimen Cohort Reason for discontinuation   \n",
       "0                           Nivolumab  Naive                Progression  \\\n",
       "1                           Nivolumab  Naive                Progression   \n",
       "2                         Monalizumab  Naive                Progression   \n",
       "3                          Ipilimumab  Naive                      Death   \n",
       "4                        Atezolizumab  Naive                Progression   \n",
       "..                                ...    ...                        ...   \n",
       "92                      Pembrolizumab  Naive                   Toxicity   \n",
       "94                          Nivolumab  Naive                      Death   \n",
       "95  Avelumab/OX40 agonist PF-04518600  Naive                Progression   \n",
       "96  Avelumab/Debio1143 (SMAC mimetic)  Naive                   Toxicity   \n",
       "97                      Pembrolizumab  Naive                Progression   \n",
       "\n",
       "            Best response  Age at advanced disease diagnosis  ...  Alive_0   \n",
       "0                   Mixed                                 45  ...        1  \\\n",
       "1          Stable disease                                 47  ...        1   \n",
       "2   Physician assessed SD                                 57  ...        1   \n",
       "3           Not evaluable                                 29  ...        1   \n",
       "4          Stable disease                                 52  ...        1   \n",
       "..                    ...                                ...  ...      ...   \n",
       "92  Physician Assessed SD                                 60  ...        1   \n",
       "94  Physician assessed PR                                 38  ...        1   \n",
       "95         Stable disease                                 69  ...        1   \n",
       "96       Partial response                                 34  ...        1   \n",
       "97  Physician assessed SD                                 50  ...        0   \n",
       "\n",
       "    Time to progression (days)  Progression_1  Clinical benefit   \n",
       "0                          179              1               NCB  \\\n",
       "1                          148              1               NCB   \n",
       "2                           79              1               NCB   \n",
       "3                           11              0               NCB   \n",
       "4                           80              1               NCB   \n",
       "..                         ...            ...               ...   \n",
       "92                         401              0               DCB   \n",
       "94                          96              0               NCB   \n",
       "95                          69              1               NCB   \n",
       "96                          51              1               NCB   \n",
       "97                         104              1               NCB   \n",
       "\n",
       "   CD8+ T cell score  Exome mut per mb  Genome mut per mb  CD274 expression   \n",
       "0           0.351869         11.095310            23.0729            4.1689  \\\n",
       "1           0.071464          3.876336             5.4552            0.7910   \n",
       "2           0.040394          2.415688             4.1274            4.0377   \n",
       "3           0.052774          6.235845            11.4871            0.6006   \n",
       "4           0.009323          4.606660             7.1503            1.8234   \n",
       "..               ...               ...                ...               ...   \n",
       "92          0.695396         84.998501            96.4079            8.4768   \n",
       "94          0.818233          2.247151             2.7416           11.2704   \n",
       "95          0.018982          3.848247             5.8036            8.7136   \n",
       "96          0.000000          5.617878             7.7940            0.0688   \n",
       "97          0.110416         33.763449            53.2769           23.8818   \n",
       "\n",
       "    M1M2 expression      Lymph related  \n",
       "0          55.51575  Non-lymph related  \n",
       "1           9.32352  Non-lymph related  \n",
       "2          50.12008      Lymph related  \n",
       "3           1.58550  Non-lymph related  \n",
       "4          38.42695  Non-lymph related  \n",
       "..              ...                ...  \n",
       "92         86.62561  Non-lymph related  \n",
       "94         47.97376  Non-lymph related  \n",
       "95          5.13403  Non-lymph related  \n",
       "96          0.51364  Non-lymph related  \n",
       "97         11.22022  Non-lymph related  \n",
       "\n",
       "[82 rows x 21 columns]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_excel('data/Supplemental-table1.xlsx')\n",
    "df = df.loc[df[\"Cohort\"] == \"Naive\"]\n",
    "df"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Compare high risk patients and low risk patients"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### a. Find risk classes\n",
    "With the ```CoxModel``` class implementing a Cox Regression, we can determine the risk class for each sample : high (class 1) or low (class 0). Because we have few data, we use a **leave one out cross validation**, which consists in fitting the model with all the dataset except 1 sample, then we predict the risk class for the test sample."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[0. 0. 1. 0. 1. 0. 1. 0. 1. 1. 0. 1. 1. 0. 0. 1. 1. 0. 1. 1. 0. 0. 0. 0.\n",
      " 1. 0. 1. 0. 1. 1. 0. 1. 1. 1. 1. 0. 0. 0. 1. 0. 1. 1. 1. 1. 0. 0. 0. 1.\n",
      " 0. 0. 0. 1. 1. 1. 1. 1. 0. 1. 1. 0. 0. 1. 0. 0. 1. 1. 1. 1. 1. 0. 1. 0.\n",
      " 1. 0. 0. 0. 0. 1. 0. 0. 1. 0.]\n",
      "[-1.30539824e+00 -1.35683044e-01 -5.61777266e-02 -3.70384841e-01\n",
      " -3.48898336e-02 -4.66706421e-01  2.51379039e-01 -2.96552238e-01\n",
      "  3.00759991e-02  5.47362269e+00 -8.26419228e-01 -4.04896877e-02\n",
      " -4.62695033e-02 -1.92475810e-01 -6.05123967e-01  6.36358883e-02\n",
      "  5.33425450e-01 -6.99439245e-01 -1.14135947e-01  3.78125634e-01\n",
      " -2.01939460e-01 -1.82683658e-01 -6.08211379e-01 -4.25488817e-01\n",
      " -9.82793434e-02 -3.80139497e-01  1.54314001e-01 -2.70510677e-01\n",
      "  2.10151883e-02 -9.21334100e-02 -1.61195279e-01 -3.02490172e-02\n",
      " -1.84891208e-02 -4.59999187e-02 -3.22309807e-02 -6.04566291e-01\n",
      " -6.18077175e-01 -7.96484108e-01 -8.61081384e-02 -3.76024082e-01\n",
      "  5.24757828e-01 -9.99136516e-02  5.56777037e-02 -6.99584485e-02\n",
      " -5.79686577e-01 -3.21008934e-01 -6.09371973e-01  4.02711536e-02\n",
      " -1.95584165e+00 -2.44539778e+00 -8.54819822e-01  7.87852321e-02\n",
      " -1.16973064e-01  2.24822840e-03 -5.74932820e-03  1.82428203e-03\n",
      " -4.11699289e-01  4.92741919e-02 -1.45158982e-02 -2.94789379e-01\n",
      " -1.34580337e-01 -1.15283830e-01 -1.25638778e-01 -3.00611405e-01\n",
      " -8.73881287e-02  6.98138117e-02 -3.54795681e-02 -2.98483593e-02\n",
      " -9.04709179e-02 -1.29360394e-01 -7.65522436e-03 -2.37066053e-01\n",
      " -5.91808220e-04 -2.02045364e-01 -1.99650998e+00 -3.08703887e-01\n",
      " -1.12167574e+00  9.63643280e-01 -1.96432175e+00 -1.20135738e-01\n",
      " -3.97826746e-02 -9.19118432e-01]\n"
     ]
    }
   ],
   "source": [
    "# Preprocessing for the label data\n",
    "X = df.loc[:,[\"CD8+ T cell score\",\"Exome mut per mb\",\"Genome mut per mb\",\"CD274 expression\",\"M1M2 expression\"]].to_numpy()\n",
    "y = np.array(list((df[['Alive_0','Overall survival (days)']].itertuples(index=False, name=None))),dtype=[('Alive_0', '?'), ('Overall survival (days)', '<f8')])\n",
    "\n",
    "# Finding the risk classes\n",
    "risk_classes, risk_scores = coxmodel.leave_one_out_cross_validation(X,y)\n",
    "print(risk_classes)\n",
    "print(risk_scores)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### b. Compute concordance index\n",
    "In this context, the concordance index measures the proportion of patients comparable pairs in which the risk score and the surviving time are concordant."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.57"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "status, time = df['Alive_0'].to_numpy().astype(bool), df['Overall survival (days)'].to_numpy()\n",
    "c_index = coxmodel.get_c_index(status, time, risk_scores)\n",
    "c_index"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### c. Compute p value of the log rank test\n",
    "The log rank test compares 2 survival curves. If the p value is low (under 5%), the 2 curves are different. Otherwise, the 2 curves are pretty similar. We make this test for the low risk (class 0) and high risk curves (class 1)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.02"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "p_value = coxmodel.log_rank_test(status.astype(int), time, risk_classes)\n",
    "p_value"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### d. Vizualize survival curves for each class"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Low risk class\n",
    "status_low, time_low = status[np.where(risk_classes==0)], time[np.where(risk_classes==0)]\n",
    "time_axis_low, prob_axis_low = coxmodel.kaplan_meier_estimation(status_low, time_low)\n",
    "\n",
    "# High risk class\n",
    "status_high, time_high = status[np.where(risk_classes==1)], time[np.where(risk_classes==1)]\n",
    "time_axis_high, prob_axis_high = coxmodel.kaplan_meier_estimation(status_high, time_high)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x700 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "time_axis_low, prob_axis_low = coxmodel.kaplan_meier_estimation(status_low, time_low)\n",
    "\n",
    "fig, ax = plt.subplots(figsize=(15,7))\n",
    "ax.step(time_axis_low, prob_axis_low, where='post',color='green',label='low risk')\n",
    "ax.step(time_axis_high, prob_axis_high, where='post',color='red',label='high risk')\n",
    "ax.set_xlabel('Time (days)')\n",
    "ax.set_ylabel('Survival probability')\n",
    "ax.set_title('Survival probability along time')\n",
    "ax.text(0,0.1,f'C-index : {c_index}')\n",
    "ax.text(0,0.05,f'p value : {p_value}')\n",
    "\n",
    "plt.legend()\n",
    "plt.savefig('km-survival-curve.png')"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.6"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
